The effect of 2-h infusion of 2-chlorodeoxyadenosine (cladribine) with prednisone in previously untreated B-cell chronic lymphocytic leukaemia-Reference-Cited by-同舟云学术

The effect of 2-h infusion of 2-chlorodeoxyadenosine (cladribine) with prednisone in previously untreated B-cell chronic lymphocytic leukaemia

Published:1997-12 Issue:14 Volume:33 Page:2347-2351
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Robak T,Błasińska-Morawiec M,Błoński J.Z,Krykowski E,Komarnicki M,Trepińska E,Kaźmierczuk M,Hansz J,Dmoszyńska A,Roliński J,Konopka L,Skotnicki A.B,Nowak W.S,Kotlarek-Haus S,Zdziarska B,Urasiński I

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference32 articles.

1. A potent new anti-lymphocyte agent: 2-chlorodeoxyadenosine. Abstr. no 568;Carson;Blood,1982

2. Synthesis 2′-deoxytubercidin, 2′-deoxyadenosin and related 2′-deoxynucleosides via a novel direct stereospecific serum salt glycosylation procedure;Kazimierczuk;J Am Chem Soc,1984

3. Specific toxicity of 2-chlorodeoxyadenosine toward resting and proliferating human lymphocytes;Carson;Blood,1983

4. Drug profile: Cladribine (2-chlorodeoxyadenosine);Beutler;Lancet,1992

5. Purine metabolism of lymphocytes;Carrera;Hematol Oncol Clin N Am,1994

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Solute Carrier Nucleoside Transporters in Hematopoiesis and Hematological Drug Toxicities: A Perspective;Cancers;2022-06-25

2. Cladribine prolongs progression-free survival and time to second treatment compared to fludarabine and high-dose chlorambucil in chronic lymphocytic leukemia;Leukemia & Lymphoma;2014-04-16

3. Beyond hairy cell: the activity of cladribine in other hematologic malignancies;Blood;2010-10-21

4. 2-Chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland;European Journal of Haematology;2009-04-24

5. Effect of a 2-hour infusion of 2-chlorodeoxyadenosine in the treatment of refractory or previously untreated Waldenström's macroglobulinemia;European Journal of Haematology;2009-04-24